Exchange Select Maximum Redness Relief Eye Drops
Exchange Select Maximum Redness Relief Eye Drops 15mL (PLD)
Approved
Approval ID
318bc025-c936-a066-e063-6294a90a4712
Product Type
HUMAN OTC DRUG LABEL
Effective Date
Jan 1, 2024
Manufacturers
FDA
Army and Air Force Exchange Service
DUNS: 001695568
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Glycerin, Naphazoline HCl
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code55301-998
Application NumberM018
Product Classification
M
Marketing Category
C200263
G
Generic Name
Glycerin, Naphazoline HCl
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 1, 2024
FDA Product Classification
INGREDIENTS (7)
NAPHAZOLINE HYDROCHLORIDEActive
Quantity: 0.03 g in 100 mL
Code: MZ1131787D
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
GLYCERINActive
Quantity: 0.5 g in 100 mL
Code: PDC6A3C0OX
Classification: ACTIB
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT